Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

YESINTEK

USTEKINUMAB-KFCE

Standard Dose
45MG/0.5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview YESINTEK is listed in Drugs@FDA under application 761406 (BLA).

Marketing status: Prescription Active ingredient USTEKINUMAB-KFCE Form and strength INJECTABLE;INJECTION - 45MG/0.5ML Sponsor BIOCON BIOLOGICS INC Submission history Latest submission status date: 2026-01-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview YESINTEK is listed in Drugs@FDA under application 761406 (BLA). Marketing status: Prescription Active ingredient USTEKINUMAB-KFCE Form and strength INJECTABLE;INJECTION - 45MG/0.5ML Sponsor BIOCON BIOLOGICS INC Submission history Latest submission status date: 2026-01-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
YESINTEK (USTEKINUMAB-KFCE) | Drug Monograph | MedicHelpline